The epidemiology of ovarian cancer: a review
Yoder, L.H.
Oncology Nursing Forum 17(3): 411-415
1990
ISSN/ISBN: 0190-535X PMID: 2188227 Document Number: 350479
Ovarian cancer is difficult to detect in an early stage when cure rates are higher. Because of this, it is important to identify women who may have a greater probability of developing the disease. The question of what factors influence a women's chances of developing ovarian cancer continues to be extremely difficult to answer. Nurses who understand the epidemiology of ovarian cancer and who are skilled in taking comprehensive health histories can play a major role in educating women to continue to obtain gynecologic screening exams, even in their postmenopausal years.
Document emailed within 1 workday
Related Documents
Tamaya, T. 2004: Epidemiology of ovarian cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 10): 435-440Daly, M.; Obrams, G.I. 1998: Epidemiology and risk assessment for ovarian cancer Seminars in Oncology 25(3): 255-264
Fukuyama, A.; Yokoyama, Y.; Wada, J.; Hashimoto, T.; Oda, T.; Sato, S.; Mizunuma, H. 2009: Two cases of ovarian cancer at an early stage incidentally detected using transvaginal ultrasonography in screening: importance of interval for ovarian cancer screening and selection of population with a high risk of ovarian cancer European Journal of Gynaecological Oncology 30(2): 208-210
Hartge, P.; Hayes, R.; Reding, D.; Sherman, M.E.; Prorok, P.; Schiffman, M.; Buys, S. 2000: Complex ovarian cysts in postmenopausal women are not associated with ovarian cancer risk factors: preliminary data from the prostate, lung, colon, and ovarian cancer screening trial American Journal of Obstetrics and Gynecology 183(5): 1232-1237
Foulkes, W.D.; Narod, S.A. 1995: Hereditary breast and ovarian cancer: epidemiology, genetics, screening and predictive testing Clinical and Investigative Medicine. Medecine Clinique et Experimentale 18(6): 473-483
Kelsey, J.L. 1979: A review of the epidemiology of human breast cancer Epidemiologic Reviews 1: 74-109
Moorman, P.G.; Havrilesky, L.J.; Gierisch, J.M.; Coeytaux, R.R.; Lowery, W.J.; Peragallo Urrutia, R.; Dinan, M.; McBroom, A.J.; Hasselblad, V.; Sanders, G.D.; Myers, E.R. 2013: Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 31(33): 4188-4198
Risteli, L.; Risteli, J.; Puistola, U.; Tomás, C.; Zhu, G.G.; Kauppila, A. 1992: Aminoterminal propeptide of type III procollagen in ovarian cancer. A review Acta Obstetricia et Gynecologica Scandinavica. Supplement 155: 99-103
Memik, F.; Gulten, M.; Nak, S.G.; Dolar, E.; Oztürk, M.; Karaaslan, Y.; Bağci, S. 1996: The epidemiology of gastrointestinal cancer in Turkey: a review of our accumulated experience Journal of Environmental Pathology Toxicology and Oncology: Official Organ of the International Society for Environmental Toxicology and Cancer 15(2-4): 209-213
Suzuki, M.; Sekiguchi, I.; Tamada, T.; Sakurabayashi, I.; Kawai, T. 1985: Clinical evaluation of a cancer antigen CA125 associated with ovarian cancer. (III) Serum CA125 levels in patients with ovarian cancer and other gynecological tumors Rinsho Byori. Japanese Journal of Clinical Pathology 33(2): 173-177
Mordel, N.; Margalioth, E.J.; Harats, N.; Ben-Baruch, N.; Schenker, J.G. 1988: Concurrence of ovarian cancer and dermatomyositis. A report of two cases and literature review Journal of Reproductive Medicine 33(7): 649-655
Jin, Y.; Pan, L-ya.; Huang, H-fang.; Shen, K.; Wu, M.; Yang, J-xin.; Lang, J-he. 2006: Treatment options for patients with recurrent ovarian cancer: a review of 54 cases Chinese Medical Sciences Journal 21(1): 11-15
Schneider, J.; Erasun, F.; Hervas, J.L.; Miñambres, J.L. 1987: Second-look and third-look laparotomies in follow-up of ovarian cancer. a critical review of 6 years' experience Zentralblatt für Gynakologie 109(4): 235-242
Rose, P.G.; Hunter, R.E. 1994: Advanced ovarian cancer in a woman with a family history of ovarian cancer, discovered at referral for prophylactic oophorectomy. A case report Journal of Reproductive Medicine 39(11): 908-910
Tanaka, K. 1989: Ovarian cancer--assessment of methods for cytogenetic analysis and chromosome aberrations found in ovarian cancer Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 80: 268-280
Li, D.-P.; Du, C.; Zhang, Z.-M.; Li, G.-X.; Yu, Z.-F.; Wang, X.; Li, P.-F.; Cheng, C.; Liu, Y.-P.; Zhao, Y.-S. 2014: Breastfeeding and ovarian cancer risk: a systematic review and meta-analysis of 40 epidemiological studies Asian Pacific Journal of Cancer Prevention: Apjcp 15(12): 4829-4837
Scotto, V.; Masci, P.; Sbiroli, C. 1985: Breast metastasis of ovarian cancer during cis-platinum therapy. A case report and review of the literature European Journal of Gynaecological Oncology 6(1): 62-65
Kuwashima, Y.; Uehara, T.; Kishi, K.; Nishimura, T.; Shiromizu, K.; Matsuzawa, M.; Takayama, S. 1994: Malignant squamous cell elements in the ovarian cancer: report of 5 cases and review of the literature In Vivo 8(6): 1063-1066
Bulanova, I.M. 2005: Clinical and radiological studies in catamnesis of the patients, treated for ovarian cancer (review of literature) Vestnik Rentgenologii i Radiologii 2005(1): 46-50
Louie, K.S.; de Sanjose, S.; Mayaud, P. 2009: Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review Tropical Medicine and International Health: Tm and Ih 14(10): 1287-1302